Cargando…
硼替佐米为基础的化疗序贯自体造血干细胞移植治疗伴1q21扩增初治多发性骨髓瘤患者疗效分析
OBJECTIVE: To explore the prognostic factors in newly diagnosed multiple myeloma (NDMM) patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation (ASCT). METHODS: We retrospectively assayed 35 NDMM patients with 1q21 a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342915/ https://www.ncbi.nlm.nih.gov/pubmed/30032568 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.06.012 |